Incremental value of the perivascular fat attenuation index surrounding the superior mesenteric artery on non-contrast CT for predicting SMA abnormalities in patients with acute abdominal pain.

Authors

Yanan Zhang, Yue Zhou, Jianbing Yin, Jia Liu, Jialei Ming, Lei Cui

Published in

Frontiers in medicine. Volume 13. Pages 1899182. Epub Sep 11, 2026.

Abstract

To evaluate the predictive value of the perivascular fat attenuation index (FAI) surrounding the superior mesenteric artery (SMA) on non-contrast CT for SMA abnormalities in acute abdominal pain and FAI's incremental utility in risk models.
This retrospective study included 262 acute abdominal pain patients (77 with SMA abnormalities, 185 controls) admitted between January 2020 and December 2025. All underwent non-contrast and contrast-enhanced CT within 48 h. Independent predictors were identified via univariate and multivariate logistic regression. The maximum area under the curve (AUC) was obtained through receiver operating characteristic analysis, and the predictive performance of models was comprehensively evaluated using net reclassification (NRI) and integrated discrimination improvement (IDI). Decision curve analyses (DCA) and calibration curves were used to evaluate the clinical utility and calibration of the models.
Independent predictors of SMA abnormalities were smoking (OR = 10.452, 95% CI: 2.528-43.219), elevated high-sensitivity C-reactive protein [hsCRP] (OR = 1.012, 95% CI: 1.001-1.023), increased SMA diameter [SMA-d] (OR = 4.414, 95% CI: 2.758-7.062), and high FAI (OR = 1.092, 95% CI: 1.053-1.132; all P < 0.05). Four models were constructed: Model A (smoking + hsCRP), Model B (Model A + SMA-d), Model C (Model A + FAI), and Model D (Model A + SMA-d + FAI). Model D achieved the highest AUC (0.970; 95% CI: 0.952-0.988), outperforming Model A (AUC = 0.734), Model B (AUC = 0.945), and Model C (AUC = 0.878; all P < 0.001). Versus Model A, Model D showed superior NRI (0.780) and IDI (0.573; both P < 0.001). Model B outperformed Model C in incremental value (NRI: 0.657 vs. 0.457; IDI: 0.460 vs. 0.295; all P < 0.001) when each was compared with Model A. DCA confirmed Model D provided maximal net clinical benefit (threshold probability: 0%-91%). The Model D nomogram demonstrated excellent calibration.
A high FAI was independently associated with SMA abnormalities, although its incremental predictive value was lower than that of SMA-d. Thus, FAI might serve as a complementary imaging biomarker rather than a stand-alone diagnostic marker. Integrating smoking status, hsCRP, SMA-d, and FAI might improve early risk stratification based on non-contrast CT and support timely diagnostic evaluation.

PMID:
42798331
Bibliographic data and abstract were imported from PubMed on 26 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.